Hiroshi Semba

Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)

Shinzoh Kudoh, Koji Takeda, Kazuhiko Nakagawa et al. · Journal of Clinical Oncology · 2006 · 365 citations · Full text

Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105

Nobuyuki Yamamoto, Kazuhiko Nakagawa, Yasumasa Nishimura et al. · Journal of Clinical Oncology · 2010 · 293 citations · Full text

Complications associated with endobronchial ultrasound-guided transbronchial needle aspiration: a nationwide survey by the Japan Society for Respiratory Endoscopy

Fumihiro Asano, Motoi Aoe, Yoshinobu Ohsaki et al. · Respiratory Research · 2013 · 263 citations · Full text

Interventional Pulmonology, Endoscopic Surgery, Japan Society +10

Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)

Koji Takeda, Shunichi Negoro, Tomohide Tamura et al. · Annals of Oncology · 2009 · 67 citations

Non-small-cell Lung Cancer, Medicine, Metronomic Therapy +10

A Phase II Trial of Gefitinib Monotherapy in Chemotherapy-Naïve Patients of 75 Years or Older with Advanced Non-small Cell Lung Cancer

Noriyuki Ebi, Hiroshi Semba, S. Tokunaga et al. · Journal of Thoracic Oncology · 2008 · 45 citations · Full text

Chemotherapy-naïve Patients, Phase Ii Trial, Medicine +8